An end-stage kidney disease patient undergoing dialysis treatment for 50 years with dialysis-related amyloidosis in multiple organs
CEN Case Reports · 01.06.2025 · 14 (4) · 665-673
DOI: 10.1007/s13730-025-01003-3 ↗Kurz gefasst
Fallbericht in der Zeitschrift CEN Case Reports, online erschienen am 01.06.2025. Verfasst von Toru Ito und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. Hauptthemen laut MEDLINE: Renal Dialysis, Amyloidosis, Kidney Failure, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Advancements in dialysis treatment have led to an increase in the number of patients undergoing long-term dialysis. These patients often experience a decline in activities of daily living (ADL) owing to various chronic kidney disease-related conditions such as mineral and bone disorders, dialysis-related amyloidosis (DRA), and cardiovascular diseases. A male patient began hemodialysis at the age of 22 years because of end-stage kidney disease caused by chronic glomerulonephritis and continued dialysis treatment for 50 years. The patient died at 72 years of age from sepsis, ischemic colitis, and pneumonia. During the course of treatment, the patient frequently underwent surgeries for carpal tunnel syndrome and destructive spondyloarthropathy, which led to a decline in ADL. An autopsy revealed β2-microglobulin amyloid deposits in multiple organs, including the heart, lungs, and intestines. Long-term dialysis treatment results in ADL impairment owing to osteoarticular disorders caused by DRA, and systemic organ deposits are potentially related to organ failures such as ischemic colitis and pneumonia. Elucidating the pathophysiology of DRA and developing more effective treatments may improve ADL and prognosis in patients undergoing long-term dialysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
- Divisions of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
- Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. yamamots@med.niigata-u.ac.jp.
- Kidney Center of Shinraku-en Hospital, Niigata, Japan.
- Department of Clinical Nutrition Science, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
ORCID-Profile: Suguru Yamamoto
Zitieren
APA
Ito, T., Kato, T., Yamamoto, S., Shimada, H., Kabasawa, H., Goto, S., Ohashi, R., & Narita, I. (2025). An end-stage kidney disease patient undergoing dialysis treatment for 50 years with dialysis-related amyloidosis in multiple organs. CEN Case Reports, 14(4), 665-673. https://doi.org/10.1007/s13730-025-01003-3
Vancouver
Ito T, Kato T, Yamamoto S, Shimada H, Kabasawa H, Goto S, et al. An end-stage kidney disease patient undergoing dialysis treatment for 50 years with dialysis-related amyloidosis in multiple organs. CEN Case Reports. 2025;14(4):665-673. doi:10.1007/s13730-025-01003-3
BibTeX
@article{Ito2025,
author = {Ito, Toru and Kato, Takashi and Yamamoto, Suguru and Shimada, Hisaki and Kabasawa, Hideyuki and Goto, Shin and Ohashi, Riuko and Narita, Ichiei},
title = {An end-stage kidney disease patient undergoing dialysis treatment for 50 years with dialysis-related amyloidosis in multiple organs},
journal = {CEN Case Reports},
year = {2025},
volume = {14},
number = {4},
pages = {665--673},
doi = {10.1007/s13730-025-01003-3}
}
EUVIMED